SLC5A2 and coronary artery disorder: Among patients with isolated CAD, 10.2% were not using beta-blockers, while 68.4% of diabetic patients were using metformin and only 12.5% were using SGLT2 inhibitors and/or GLP1 agonists (Table 2).